MINI FUTURE LONG - BB BIOTECH N Share Price

Certificat

DE000ME3SDV5

Market Closed - Börse Stuttgart 14:13:29 28/06/2024 BST
0.51 EUR -1.92% Intraday chart for MINI FUTURE LONG - BB BIOTECH N
Current month+4.08%
1 month-8.93%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 0.51 -1.92%
27/06/24 0.52 -11.86%
26/06/24 0.59 +3.51%
25/06/24 0.57 +11.76%
24/06/24 0.51 +45.71%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 02:13 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellCALL
Underlying BB BIOTECH AG
Issuer Morgan Stanley
WKN ME3SDV
ISINDE000ME3SDV5
Date issued 16/11/2023
Strike 35.28 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.223

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
40.1 CHF
Average target price
47.7 CHF
Spread / Average Target
+18.95%
Consensus